What is Urea Breath Test Systems Market?
The urea breath check may be a check for identification of the presence of a bacterium, Helicobacter pylori (H. pylori) infection within the abdomen. H. pylori cause inflammation, ulcers, and atrophy of the abdomen. The check conjointly is also accustomed to demonstrate that H. pylori are eliminated by treatment with antibiotics. The carbamide breath check is basically adopted for its non-invasive, fast, and most correct results to observe the presence of active H. pylori infection.
The market study is being classified by Type (Urea Breath Test Kits and Urea Breath Test Analyzer), by Application (Hospitals, Specialized Clinics, Laboratories and Others) and major geographies with country level break-up.
Sercon Ltd (United Kingdom), Shenzhen Zhonghe Headway Bio-Sci & Tech Co Ltd. (China), Exalenz Bioscience Ltd. (Israel), Beijing Richen-Force Science & Technology Co Ltd (China), Kibion AB (Sweden), AdvaCare Pharma (United States), Kizlon Inc. (United Kingdom) and Meridian Bioscience Inc. (United States) are some of the key players profiled in the study.
Segment Analysis
Analyst at AMA have segmented the market study of Global Urea Breath Test Systems market by Type, Application and Region.
On the basis of geography, the market of Urea Breath Test Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Europe region held largest market share in the year 2020. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Rising Adoption of Non-Invasive and Real-Time Testing Systems
- Growing Demand for Point of Care Testing Devices
Market Trend
- Increasing Investments in R&D Processes to Offer Distinguished Solutions and Gain Competitive Advantage
Restraints
- Lack of Awareness Regarding H. Pylori Infection
Opportunities
- Development of Advanced Diagnostics Kits like Advent of Home Diagnostic Kits for H. Pylori Testing
Challenges
- Lack of Skilled Professionals for Invasive Testing
Market Leaders and some development strategies
In 2021, Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, acquired acquire the North American BreathTek business from Otsuka America Pharmaceutical, Inc. This acquisition will bolster Meridian’s position as a leading provider of gastrointestinal diagnostic solutions.
In 2017, Exalenz Bioscience launched the BreathID Hp urea breath testing product line by introducing the new BreathID Hp Lab system. The BreathID Hp systems are intuitive and time-efficient products that detect active carcinogenic H. pylori bacterial infection.
Key Target Audience
Urea Breath Test Systems Provider, Equipment Manufacturers, Software Developer, Research Institutes, End-User Industry and Others